Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases
Fouladi D, Zarghampour M, Pandey P, Pandey A, Varzaneh F, Ghasabeh M, Khoshpouri P, Kamel I. Baseline 3D-ADC outperforms 2D-ADC in predicting response to treatment in patients with colorectal liver metastases. European Radiology 2019, 30: 291-300. PMID: 31209620, DOI: 10.1007/s00330-019-06289-3.Peer-Reviewed Original ResearchConceptsShort-term response to treatmentResponse to treatmentHepatic colorectal metastasesPredicting response to treatmentColorectal metastasesSystemic chemotherapyPrediction of response to treatmentPercentile of ADCColorectal liver metastasesTrans-arterial chemoembolizationSystemic chemotherapy patientsBaseline ADCNonresponding lesionsRadioembolization patientsMetastatic lesionsLiver metastasesTACE patientsRadioembolizationPatientsChemotherapy patientsInclusion criteriaResponse to different treatmentsMR imagingTACEROI-based
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply